Synonyms: CVT-303 | Ranexa® | RS-43285 | RS-43285-003
ranolazine is an approved drug (FDA (2006), EMA (2008))
Compound class:
Synthetic organic
Comment: The mechanism of action of ranolazine is largely unknown, but may have some antianginal effects by inhibition of the late sodium current in cardiac cells.
![]() View more information in the IUPHAR Pharmacology Education Project: ranolazine |
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (2006) | EMA (2008) |
IUPAC Name ![]() |
N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}ethanimidic acid |
International Nonproprietary Names ![]() |
|
INN number | INN |
5946 | ranolazine |
Synonyms ![]() |
CVT-303 | Ranexa® | RS-43285 | RS-43285-003 |
Database Links ![]() |
|
CAS Registry No. | 95635-55-5 |
ChEMBL Ligand | CHEMBL1404 |
DrugBank Ligand | DB00243 |
DrugCentral Ligand | 2359 |
GtoPdb PubChem SID | 178103865 |
PubChem CID | 56959 |
Search Google for chemical match using the InChIKey | XKLMZUWKNUAPSZ-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | XKLMZUWKNUAPSZ |
Search PubMed clinical trials | ranolazine |
Search PubMed titles | ranolazine |
Search PubMed titles/abstracts | ranolazine |
UniChem Compound Search for chemical match using the InChIKey | XKLMZUWKNUAPSZ-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | XKLMZUWKNUAPSZ-UHFFFAOYSA-N |
Wikipedia | Ranolazine |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Ranolazine (links to external site)
Cat. No. HY-B0280 |